Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer

Colorectal Disease

Volumn 10, Issue 6, 2008, Pages 563-568

  Suárez, Javier ^a   Vera, R ^a   Balen E ^a   Gomez M ^a   Arias, F ^a   Lera, J M ^a   Herrera, J ^a   Zazpe, C ^a  

^a Universidad Pública de Navarra   (Spain)

Author keywords

Pathological response; Preoperative chemoradiotherapy; Rectal cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; COLOSTOMY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ECHOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; LOG RANK TEST; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; STATISTICAL SIGNIFICANCE; STOMA; SURGICAL TECHNIQUE; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; SEX FACTORS;

EID: 44949180871     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2007.01424.x     Document Type: Article

References (31)

1. Kapiteijn E, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-46.
2. Sauer R, Becker H, Hohenberger W et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-40.
3. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997; 336: 980-7.
4. Bosset JF, Collette L, Calais G, Mineur L, Maingon F, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-23.
5. Gerard JP, Bonnetain F, Conroy T, Chapet O, Bouche O, Closon-Dejardin MT, Untereiner M, Leduc B, Francois L, Bedenne L. Preoperative (preop) radiotherapy (RT)/-5FU/folinic acid (FA) in T3-4 rectal cancers: Results of de FFCD 9203 randomized trial. ASCO Meeting Abstracts, 1 June 2005: 3504.
6. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 2000; 43: 1075-83.
7. Mandard AM, Dalibard F, Mandard A et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Cancer 1994; 73: 2680-6.
8. Bozzetti F, Andreola S, Rossetti C, Zucali R, Meroni E, Baratti D, Bertario L, Doci R, Gennari L. Preoperative radiotherapy for resectable cancer of the middle-distal rectum: Its effect on the primary lesion as determined by endorectal ultrasound using flexible echo colonoscope. Int J Colorectal Dis 1996; 11: 283-6.
9. Ryan R, Gibbons D, Hyland JMP, Treanor D, White A, Mulcahy HE, O'Donoghue DP, Moriarty M, Fennelly D, Sheahan K. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005; 47: 141-6.
10. Rullier A, Laurent C, Vendrely V, Le Bail B, Bioulac-Sage P, Rullier E. Impact of colloid response on survival after preoperative radiotherapy in locally advancer rectal carcinoma. Am J Pathol 2005; 29: 602-6.
11. Jass JR, O'Brien MJ, Riddell RH, Snover DC, on behalf of the Association of Directors of Anatomic and Surgical Pathology. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Hum Pathol 2007; 38: 537-45.
12. Boulis-Wassif S, Gerard A, Loygue J, Camelot D, Buyse M, Duez N. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Trial of the European organization on Research and Treatment of cancer Gastrointestinal Cooperative Group. Cancer 1984; 53: 1811-8.
13. Mehta VK, Poen J, Ford F, Edelstein PS, Vierra M, Bastidas AJ, Young H, Fisher G. Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer. Dis Colon Rectum 2001; 44: 52-8.
14. Biondo S, Navarro M, Marti-Rague J, Arriola E, Pares D, Del Río C, Cambray M, Novell V. Response to neoadjuvant therapy for rectal cancer: Influence on long-term results. Colorectal Dis 2005; 7: 472-9.
15. Rödel C, Martus P, Papadoupolos T, Füzesi L, Klimpfinger M, Fietkau R, Liersch T, Hohenberger W, Sauer R, Witekind C. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005; 23: 8688-96.
16. García-Aguilar J, Hernández de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improvedsurvival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 2003; 46: 298-304.
17. Theodoropoulos G, Wise WE, Padmanabhan A, Kerner BA, Taylor CW, Aguilar PS, Khanduja KS. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 2002; 45: 895-903.
18. Mehta V, Cho C, Ford JM et al. Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound staged T3 rectal cancer. Int J Radiat Oncol Biol Phys 2003; 55: 132-7.
19. Rödel C, Grabenbauer GG, Papadopoulos T, Hohenberger W, Schmoll HJ, Sauer R. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 2003; 21: 2098-104.
20. Guillem JG, Chessin DB, Cohen AM et al. Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 2005; 241: 829-36.
21. Janjan NA, Khoo VS, Abbruzzese J et al. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: The MD Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 1999; 44: 1027-38.
22. Willett CG, Warland G, Coen J, Shellito PC, Compton CC. Rectal cancer: the influence of tumor proliferation on response to preoperative irradiation. Int J Radiat Oncol Biol Phys 1995; 32: 57-61.
23. Rau B, Sturm I, Lage H et al. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal cancer treated with preoperative radiochemotherapy. J Clin Oncol 2003; 21: 3391-401.
24. Rödel C, Grabenbauer GG, Papadopoulos T, Bigalke M, Gunther K, Schick C, Peters A, Sauer R, Rodel F. Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer. Int J Radiat Oncol Biol Phys 2002; 52: 294-303.
25. Scott N, Hale A, Deakin M, Hand P, Adab FA, Hall C, Williams GT, Elder JB. A histopathologic assessment of the response of rectal adenocarcinoma to combination chemo-radiotherapy: Relationship to apoptotic activity, p53 and bcl-2 expression. Eur J Surg Oncol 1998; 24: 169-73.
26. Rouanet P, Fabr JM, Dubois JB, Dravet F, Saint Aubert B, Pradel J, Ychou M, Solassol C, Pujol H. Conservative surgery for low rectal carcinoma after high-dose radiation. Functional and oncological results. Ann Surg 1995; 221: 67-73.
27. Ueno H, Mochizuki H, Hashiguchi Y, Ishikawa K, Fujimoto H, Shinto E, Hase K. Preoperative paramenters expanding the indication of sphincter preserving surgery in patients with advanced local cancer. Ann Surg 2004; 239: 34-42.
28. Brown CL, Ternent CA, Thorson AG, Christensen MA, Blatchford GJ, Shashidharan M, Haynatzky GR. Response to preoperative chemoradiation in stage II and III rectal cancer. Dis Colon Rectum 2003; 46: 1189-93.
29. Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE, Soreide O. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002; 89: 327-34.
30. Birbeck KF, Macklin CP, Tiffin NJ et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002; 235: 449-57.
31. Nagtegaal ID, Marijnen CA, Kranenbarg EK. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: Not one millimetre but two millimetres is the limit. Am J Surg Pathol 2002; 26: 350-7.